The 25th Congress of the European Hematology Association (EHA) 2020, 11–21 June, will see hematology experts from around the globe congregate online for a spectacular show of the latest research outputs.

Key data on novel agents, biomarkers, cellular therapy, patient-reported outcomes, genomic insights, transplant research, and more was showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, VOD, ITP, PNH, thalessemia, and beyond.

View all videos

EHA 2020

The 25th Congress of the European Hematology Association (EHA) 2020
11–21 June 2020

Our next Mid-Size Event, #EBMT_Summit_COVID, is open for registration! This Summit will be a 3-day meeting, reviewing essential aspects of SARS-CoV-2. Check out the Preliminary Programme and more event information on our website ➡️ https://www.ebmt.org/events/ebmt-summit-covid-19
#COVID19 #COVID #EBMT

From biology to trial updates, we’re covering all the latest #HemOnc news from #AACR21 🙌

Join us at 👉http://VJHemOnc.com👈 and follow @VJHemOnc 💻

@AACR #Leukemia #Lymphoma #Myeloma #MPNsm #Myelofibrosis #CLLsm #AMLsm #ALLsm #ImmunoOnc #CART

#COMy21 is introducing snapshot talks that cover novel developments in just 10 minutes. Hear more from @Mohty_EBMT👇

#COMy21 details: 👉https://tinyurl.com/p8cpne87👈

Want to keep up with the fast-moving field? Check out our myeloma channel: https://tinyurl.com/54d4gsdw

#HemOnc #MMSM

The post-EBMT Trainee #VJSessions is tomorrow!

Register your place to hear all about the new EBMT Trainee Committee

14th April 1PM EST/6PM GMT/7PM CEST http://ow.ly/KiSO50EnaER

@VJHemOnc #EBMT21 #OncoAlert #BMTsm #HemOnc #ImmunoOnc #tcellrx

Load More...

EHA 2020

The 25th Congress of the European Hematology Association (EHA) 2020
11–21 June 2020

The 25th Congress of the European Hematology Association (EHA) 2020, 11–21 June, will see hematology experts from around the globe congregate online for a spectacular show of the latest research outputs.

Key data on novel agents, biomarkers, cellular therapy, patient-reported outcomes, genomic insights, transplant research, and more was showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, VOD, ITP, PNH, thalessemia, and beyond.

View all videos

Our next Mid-Size Event, #EBMT_Summit_COVID, is open for registration! This Summit will be a 3-day meeting, reviewing essential aspects of SARS-CoV-2. Check out the Preliminary Programme and more event information on our website ➡️ https://www.ebmt.org/events/ebmt-summit-covid-19
#COVID19 #COVID #EBMT

From biology to trial updates, we’re covering all the latest #HemOnc news from #AACR21 🙌

Join us at 👉http://VJHemOnc.com👈 and follow @VJHemOnc 💻

@AACR #Leukemia #Lymphoma #Myeloma #MPNsm #Myelofibrosis #CLLsm #AMLsm #ALLsm #ImmunoOnc #CART

#COMy21 is introducing snapshot talks that cover novel developments in just 10 minutes. Hear more from @Mohty_EBMT👇

#COMy21 details: 👉https://tinyurl.com/p8cpne87👈

Want to keep up with the fast-moving field? Check out our myeloma channel: https://tinyurl.com/54d4gsdw

#HemOnc #MMSM

The post-EBMT Trainee #VJSessions is tomorrow!

Register your place to hear all about the new EBMT Trainee Committee

14th April 1PM EST/6PM GMT/7PM CEST http://ow.ly/KiSO50EnaER

@VJHemOnc #EBMT21 #OncoAlert #BMTsm #HemOnc #ImmunoOnc #tcellrx

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter